Hypothesis

Both thymosin β4 (TB-4) and BPC-157 enhance autophagic flux not by activating the canonical ULK1‑Beclin‑1 pathway, but by stabilizing HIF‑1α under normoxic conditions, which in turn transcriptionally upregulates DAPK1 and Rubicon to drive LC3‑associated phagocytosis (LAP). This positions autophagy as a stress‑gated rationing checkpoint that decides which cytoplasmic constituents are sacrificed for survival, rather than a constitutive housekeeping program.

Mechanistic Rationale

• HIF‑1α stabilization: TB-4 has been shown to inhibit prolyl hydroxylase domain (PHD) proteins in macrophages exposed to Aspergillus conidia, preventing HIF‑1α degradation (see [1]). BPC-157, though mechanistically opaque, contains a hydrophobic pentapeptide motif that can bind Fe²⁺ and competitively inhibit PHD activity, a property shared with known HIF stabilizers such as dimethyloxalylglycine.
• Transcriptional boost: Elevated HIF‑1α drives HIF‑responsive elements (HRE) in the promoters of DAPK1 and Rubicon (RUBCN), increasing their mRNA and protein levels specifically during inflammatory or infectious stress.
• Non‑canonical LAP execution: DAPK1 phosphorylates the phagocytic NADPH oxidase complex (NOX2), facilitating Rubicon‑dependent recruitment of the PI3K‑C3 complex (VPS34‑Beclin‑1‑ATG14L) to nascent phagosomes, thereby lipidating LC3 onto the phagosomal membrane without requiring ULK1 activation.
• Rationing outcome: The LAP‑derived autophagosome preferentially engulfs oxidatively damaged proteins, lipid droplets, or intracellular pathogens, providing a

Hypothesis We propose that dynamic changes in phosphoproteomic signatures of metabolic enzymes, when coupled with real‑time shifts in specific lipid metabolites, can predict response to immune checkpoint blockade (ICB) in gastric cancer patients more accurately than static genomic or transcriptomic markers.

Mechanistic rationale

1. ICB efficacy depends on the ability of tumor cells to present antigens and sustain an inflamed microenvironment.
2. Phosphorylation of metabolic regulators such as PHGDH, ACLY, and ACSL1 redirects flux toward the hexosamine biosynthetic pathway and phospholipid remodeling, generating immunosuppressive lipids like ceramides and sphingosine‑1‑phosphate.
3. These lipid species modulate dendritic cell maturation and T‑cell infiltration, creating a feedback loop that either sustains or dampens immune activation.
4. Therefore, a combined read‑out of (a) site‑specific phosphorylation on metabolic enzymes and (b) the concentration of downstream immunosuppressive lipids captures the functional state that governs ICB sensitivity.

Testable predictions

• Patients exhibiting high basal phosphorylation of PHGDH‑Ser14 and elevated ceramide‑16:0 will show reduced progression‑free survival after anti‑PD‑1 therapy.
• Pharmacologic inhibition of the kinase driving PHGDH phosphorylation (e.g., CDK2) will decrease ceramide production and increase CD8⁺ T‑cell infiltration in pretreatment biopsies.
• Longitudinal sampling (baseline, on‑treatment day 8, and progression) will reveal that a decrease in phospho‑PHGDH concurrent with a drop in ceramide levels

Hypothesis

High mTORC1 activity drives a "civilization" program characterized by increased ribosome biogenesis, nucleolar activity, and anabolic metabolism that renders tumor cells dependent on functional autophagy to manage proteotoxic stress. Inhibiting mTORC1 alone pushes these cells into a low‑mTOR survival state, but combined mTORC1/2 inhibition with autophagy blockade creates a synthetic lethal interaction that selectively eliminates the high‑mTORC1 subpopulation while sparing low‑mTORC1 cells that already rely on autophagy for survival.

Mechanistic Rationale

• Civilization‑linked anabolic burst: mTORC1 phosphorylates S6K and 4EBP1, boosting translation of ribosomal proteins and nucleolar factors (e.g., fibrillarin, NPM1)【1】. This elevates protein synthesis load and generates misfolded protein burden that must be cleared by autophagy‑lysosomal flux.
• Feedback‑driven survival switch: Chronic mTORC1 inhibition triggers REDD1‑dependent repression and activates AMPK‑ULK1 autophagy, allowing cells to adopt a stress‑resistant, low‑mTOR phenotype akin to longevity pathways【2】.
• Synthetic lethality logic: When mTORC1 signaling is high, autophagy becomes a non‑redundant buffering system. Simultaneous blunt inhibition of mTORC1/2 (preventing compensatory rebound) and pharmacological inhibition of autophagy flux (e.g., chloroquine or hydroxychloroquine) overwhelms proteostasis, triggering apoptosis preferentially in the high‑mTORC1 compartment【3】.

Testable Predictions

1. Subpopulation depletion: In patient‑derived xenografts or organoids with hete

Hypothesis

In aged somatic cells, supernumerary centrosomes are not merely clustered for survival; the intrinsic age difference between centrosomes creates a biased spindle that non‑randomly segregates chromosomes (and associated DNA damage) toward the daughter inheriting the older centrosome. This bias, amplified by KIFC1‑mediated clustering, fuels a gradual accumulation of damaged genomes in a subset of cells, driving senescence‑associated secretory phenotype (SASP) and tissue‑level decline. Consequently, inhibiting KIFC1 should (i) increase merotelic attachments specifically at old‑centrosome poles, (ii) exacerbate the segregation bias, and (iii) push damaged cells into apoptosis or senescence rather than allowing their survival through pseudo‑bipolar division.

Mechanistic Rationale

1. Centrosome age creates PCM asymmetry – older centrosomes (marked by cenexin‑Plk1) recruit more pericentrin, γ‑tubulin and Cdk5Rap2, generating a larger microtubule‑nucleating capacity 3.
2. Clustering forces the two pole‑like masses together – KIFC1 bundles microtubules from amplified centrosomes into a pseudo‑bipolar spindle 4. When the clustered mass contains a mix of old and new centrosomes, the stronger nucleation activity of the old centrosomes skews microtubule density toward that side of the spindle.
3. Merotelic attachments arise preferentially at the denser pole – higher microtubule density increases

Hypothesis

It's known that with age, lysosomal free cholesterol accumulates and activates SREBP2, which in turn represses TFEB transcriptional activity and promotes expression of Rubicon and mTORC1 regulators, creating a self‑reinforcing brake that suppresses autophagy at initiation, autophagosome formation, and lysosomal fusion. This cholesterol‑SREBP2‑TFEB axis explains why multiple autophagy checkpoints are inhibited simultaneously and why removing single brakes (e.g., Rubicon knockdown) only partially restores flux unless lysosomal cholesterol is also lowered.

Mechanistic Model

• Lysosomal cholesterol buildup → SREBP2 cleavage → nuclear SREBP2.
• Nuclear SREBP2 binds TFEB promoter regions, reducing TFEB mRNA and protein levels.
• Reduced TFEB diminishes transcription of lysosomal and autophagy genes, lowering VPS34‑ULK1 complex activity.
• SREBP2 also upregulates RUBCN (Rubicon) transcription and enhances mTORC1 signaling via increased lysosomal amino acid sensing.
• Elevated Rubicon blocks autophagosome‑lysosome fusion; hyperactive mTORC1 phosphorylates TFEB, retaining it in the cytoplasm.
• The combined effect stalls autophagy at three checkpoints: initiation (ULK1), phagophore expansion (LC3 lipidation via ATG3/7), and fusion.

Testable Predictions

1. It's expected that aged tissues will show higher lysosomal free cholesterol, increased nuclear SREBP2, and decreased TFEB protein compared with young controls.
2. It's predicted that pharmacological depletion of lysosomal cholesterol (using cyclodextrin or NPC1 overexpression) will reduce SREBP2 activation, in

Hypothesis Reactivation of formerly silent X‑linked genes during aging increases the expression of HSP70 co‑chaperones and lysosomal adaptors that potentiate BAG3‑dependent selective autophagy, thereby providing XX individuals with a proteostatic advantage that mitigates age‑related proteinopathy and extends healthspan.

Mechanistic rationale

• In aged female mouse hippocampus, 19 Xi‑linked genes escape inactivation [3]. Many of these encode proteins that modulate the HSP70‑BAG3 axis (e.g., HSPA1L, BAG2, DNAJB6).
• BAG3 expression rises with age and drives ubiquitin‑independent clearance of aggregated tau and other substrates [5], [6]. Its activity depends on HSP70 binding and on co‑chaperones that stabilize the complex.
• Increased dosage of X‑linked HSP70‑related genes raises HSP70 availability, enhances BAG3‑HSP70 binding, and accelerates cargo loading onto autophagosomes, thus lowering steady‑state levels of toxic aggregates.
• Males, with a single X, cannot achieve the same boost in HSP70 co‑chaperone levels when Xi reactivation occurs, leaving them with weaker BAG3‑mediated flux and greater vulnerability to proteotoxic stress.

Testable predictions

1. In aged female mice, pharmacological or genetic inhibition of X‑linked gene escape (e.g., using Xi‑targeted antisense oligos) will reduce hippocampal HSP70 levels, diminish BAG3‑dependent autophagy flux, and accelerate accumulation of phosphorylated tau compared with cont

Hypothesis

Age‑associated NAD+ decline causally suppresses α‑Klotho transcription in renal tubular cells through SIRT1‑dependent deacetylation of histone H3 lysine 9 (H3K9) and relaxation of repressive chromatin at the Klotho promoter, thereby linking NAD+ metabolism to the FGF23‑Klotho axis.

Mechanistic Rationale

• SIRT1 is an NAD+-dependent deacetylase that removes acetyl groups from histones and transcription factors, promoting a closed chromatin state when NAD+ is abundant; conversely, low NAD+ reduces SIRT1 activity, leading to hyperacetylation of repressive complexes and increased binding of p16INK4a‑containing Polycomb‑repressive complexes to the Klotho promoter [4].
• Hyperacetylated H3K9ac at the Klotho locus has been shown to recruit HDAC‑containing repressors that silence transcription in senescent cells; reduced SIRT1 activity would therefore exacerbate this repressive mark.
• Preliminary data indicate that NAD+ boosters (NR, NMN) increase SIRT1 activity and decrease p16INK4a expression in kidney epithelium [5], suggesting a feedback loop where NAD+ restoration could alleviate p16‑mediated Klotho repression.
• Thus, NAD+ loss does not merely parallel Klotho decline; it actively rewrites the epigenetic landscape to dampen Klotho expression, positioning NAD+ upstream of the Klotho‑FGF23 phosphate‑regulatory axis.

Predictions

1. Acute NAD+ depletion in cultured human proximal tubular cells will reduce SIRT1 activity, increase H3K9ac at the Klotho promoter, and lower Kloth

{ "title": "Intermittent NMN dosing before exercise amplifies SIRT1 activity in human skeletal muscle via AMPK‑NAMPT coupling", "body": "# Hypothesis\n\nStatement: Taking oral NMN (500 mg) 30 minutes prior to high‑intensity interval training (HIIT) sessions three times per week for eight weeks will increase skeletal muscle SIRT1 deacetylase activity by at least 20 % compared with an equivalent total weekly dose of NMN given continuously (same total amount split into daily doses) in healthy middle‑aged adults.\n\n## Rationale\n\n- Oral NMN reliably raises circulating NAD+ within two weeks 1.\n- In rodents, NMN‑induced metabolic benefits require SIRT1; SIRT1 knockout blunts these effects 2.\n- Human data lack direct tissue‑specific SIRT1 activity readouts despite NAD+ elevation 1.\n- Exercise activates AMPK, which phosphorylates and stabilizes NAMPT, the rate‑limiting enzyme in the NAD+ salvage pathway 4.\n- AMPK activation also reduces intracellular nicotinamide (NAM) levels by increasing its consumption in NAD+ synthesis, thereby relieving SIRT1 inhibition 4.\n- Combining NMN‑driven NAD+ precursors with exercise‑induced NAMPT up‑regulation should synergistically boost the NAD+:NAM ratio, a

Hypothesis

Aging reflects a topological constraint: as organisms age, the high‑dimensional space of gene expression loses independent loops and voids, collapsing onto a lower‑dimensional attractor that simultaneously drives the classic hallmarks.

Mechanistic Basis

Recent work shows that aging hallmarks form an interconnected network [1] and that transcriptional shifts resemble those of long‑lived states [2]. Age‑invariant genes, enriched for protein‑stability pathways, are missing from epigenetic alteration, senescence, and extracellular‑matrix modules [3], hinting that these three processes sit at a boundary where adaptive compensation fails. Persistent homology can detect transient cell states during differentiation [4]; we propose that an analogous analysis will reveal a conserved loss of specific Betti numbers (e.g., β1 and β2) as chronological age advances. This loss represents a Topological Lock that reduces the number of viable expression trajectories, forcing cells into a limited set of states that manifest as epigenetic drift, secretory senescence, and matrix remodeling.

Testable Predictions

1. Single‑cell RNA‑seq from multiple tissues across the lifespan will show a stereotyped, species‑specific decline in the persistence of 1‑dimensional loops (β1) and 2‑dimensional voids (β2) at a conserved physiological age, independent of genetic background.
2. Interventions known to extend lifespan (dietary restriction, rapamycin, genetic reduction of IGF‑1 signaling) will preserve higher Betti numbers longer than controls, correlating w

Hypothesis

Individuals with higher baseline hepatic SIRT1 activity and a gut microbiome enriched for bile‑acid‑transforming bacteria (e.g., Bacteroides vulgatus, Clostridium scindens) will exhibit greater berberine‑stimulated AMPK phosphorylation, leading to larger reductions in fasting glucose and HbA1c. Conversely, low SIRT1 or a microbiome lacking 7α‑dehydroxylating capacity will blunt AMPK activation and attenuate metabolic benefits.

Rationale

Berberine lowers glucose primarily via AMPK activation [3]. AMPK activity is modulated by cellular NAD⁺ levels, which are regulated by SIRT1 deacetylase; SIRT1 can directly activate LKB1, the upstream kinase of AMPK [1]. Gut microbiota influence host bile acid pools; secondary bile acids such as deoxycholic acid (DCA) act as agonists of TGR5 and FXR, pathways that cross‑talk with AMPK to enhance insulin sensitivity [7]. Prior work shows berberine reshapes the microbiome [4], but no study has linked baseline bile‑acid‑metabolizing capacity to the magnitude of AMPK activation.

Predictions

1. Baseline hepatic SIRT1 mRNA (measured in peripheral blood mononuclear cells as a surrogate) will positively correlate with the change in p‑AMPK/AMPK ratio after 4 weeks of berberine (1 g/day).
2. Stool metagenomic enrichment for B. vulgatus and *

Hypothesis

The senolytic potency of quercetin phytosome exceeds that of isoquercetin (or free quercetin) because the phytosome formulation promotes greater lymphatic uptake and tissue retention, leading to higher intracellular concentrations of quercetin aglycone within senescent cells despite comparable or only modestly elevated plasma exposure.

Mechanistic Rationale

• Lymphatic bypass: Lecithin‑based phytosomes incorporate quercetin into mixed micelles that are taken up by intestinal enterocytes via the secretory pathway, facilitating entry into the lymphatic circulation and reducing first‑pass metabolism 2. This route yields higher drug concentrations in peripheral tissues (e.g., lung, liver, adipose) where senescent cells accumulate.
• Intracellular aglycone release: Within target cells, phospholipase‑A2 hydrolyzes the phytosome complex, liberating quercetin aglycone directly into the cytosol. This avoids reliance on extracellular β‑glucuronidase activity that limits the efficacy of isoquercetin‑derived glucuronides.
• Membrane perturbation: The phospholipid carrier integrates into cellular lipid rafts, increasing membrane fluidity and facilitating passive diffusion of the aglycone into senescent cells, which often exhibit altered lipid composition.

These steps suggest that tissue‑level quercetin aglycone exposure—and thus senolytic activity—may be decoupled from plasma AUC measurements.

Testable Predictions

1. Tissue quercetin levels: After a single 500 mg oral dose, querc

Hypothesis

Multi‑omics aging clocks lose predictive power when batch correction removes true biological covariance between host epigenetics and microbiome‑derived metabolites. We hypothesize that a coupled batch‑correction strategy that explicitly preserves cross‑omics manifold alignment will uncover a causal microbiome‑epithelial axis: gut‑derived short‑chain fatty acids (SCFAs) and endotoxin levels modulate DNA‑methylation dynamics in intestinal epithelial cells, accelerating epigenetic aging locally and systemically. This axis explains why multi‑omics clocks show tissue‑specific patterns and why naive per‑omics correction attenuates those signals.

Mechanistic Rationale

1. Microbial metabolites as epigenetic modulators – Butyrate and propionate inhibit histone deacetylases and influence TET enzyme activity, altering CpG methylation rates in colonocytes【4】.
2. Age‑related gut barrier decline – Increased permeability lets lipopolysaccharide (LPS) enter circulation, triggering low‑grade inflammation that feeds back on DNA‑methylation clocks in blood and liver【1】.
3. Covariance as signal, not noise – In young individuals, metabolite levels and methylation states co‑vary to maintain homeostasis; with age, this coupling shifts, creating a divergent manifold that captures biological age beyond what any single omic layer shows【2】.
4. Current correction methods erase this coupling – Per‑omics batch correction (e.g., ComBat, per‑layer VAEs) treats each data type independently, discarding the very cross‑omic correlations that constitute the microbiome‑epitheli

Hypothesis

The longevity benefits of hormesis depend on a transient but sufficient rise in the NAD+/NADH ratio that drives acetyl-CoA production, thereby enabling CBP/p300‑mediated H3K27ac deposition at stress‑response enhancers. When this metabolic signal crosses a threshold duration, the resulting chromatin mark becomes self‑sustaining through a positive feedback loop involving mitochondrial ROS‑dependent IDH2 activity, which replenishes acetyl‑CoA locally. Stressors that fail to maintain NAD+/NADH elevation long enough produce only transient H3K27ac that is erased after the stimulus ends, explaining why some hormetic interventions yield short‑lived adaptation.

Mechanistic Basis

• NAD+‑dependent activation of SIRT3 increases IDH2 deacetylation, boosting mitochondrial NADPH and citrate export, which fuels cytosolic acetyl‑CoA synthesis via ACLY.
• Elevated acetyl‑CoA raises nuclear H3K27ac at promoters of sod‑3, clt‑1/2 and gpx‑6/7, reinforcing their transcription.
• Sustained H3K27ac recruits BRD4, which keeps RNA polymerase II paused in a poised state, allowing rapid re‑activation upon subsequent stress and stabilizing the epigenetic memory.
• This loop is broken when NAD+/NADH falls, leading to reduced IDH2 activity, lower acetyl‑CoA, and HDAC‑mediated deacetylation.

Testable Predictions

1. Pharmacological inhibition of ATP‑citrate lyase (ACLY) during a hormetic pulse will block lasting H3K27ac accumulation and abolish lifespan extension in C. elegans, even though ROS signaling and Nrf2 activation remain intact.
2. Conversely, boosting acetyl‑CoA v

Hypothesis

Autophagy functions as a competitive triage system where cargo receptors vie for limited LC3‑II binding sites. With aging, the expression and post‑translational modification of key receptors (p62/SQSTM1, OPTN, NDP52, TAX1BP1, FAM134B, ATG39/40) become skewed, altering the zero‑sum game and causing chronic misallocation of autophagic capacity. We propose that this receptor‑level dysregulation—not a global loss of autophagy flux—drives age‑associated organelle selectivity, preferentially degrading mitochondria while sparing ER or protein aggregates, thereby amplifying ROS‑mediated damage and inflammaging.

Mechanistic basis

1. Receptor saturation kinetics shift – In young cells, stress‑specific induction balances receptor levels (e.g., starvation ↑ ATG39/40, proteotoxic stress ↑ p62). Aging blunts stress‑responsive transcription factors (FOXO, NRF2) and elevates basal p62 phosphorylation, increasing its affinity for LC3 and oligomerization propensity. This gives p62 a persistent competitive edge, sequestering LC3‑II even when aggregate load is low.

2. Spatial exclusion amplified – Receptors such as FAM134B (ER‑sheet) and RTN3L (ER‑tubule) normally partition ER subdomains. Age‑related ER stress upregulates FAM134B, expanding its condensate footprint and sterically hindering RTN3L‑mediated tubule turnover. The result is a biased ER‑phagy that favors sheet removal, disrupting ER‑mitochondria calcium coupling.

3. Mitophagy starvation – Because p62 and OPTN also bind ubiquitinated mitochondria, their chronic overexpression outcompetes TAX1BP1 for LC

Hypothesis: Ordered Collagen Fragment Clearance via CD206‑Dependent Lysosomal Exocytosis Maintains Adipose Proteostasis

Core idea In expanding adipose tissue, a proteostatic program actively sequesters pericellular collagen I fragments through CD206‑mediated endocytosis in M2‑like macrophages, followed by lysosomal processing and exocytosis of harmless peptides. When this flux is overwhelmed—by hypoxia‑driven TGF‑β up‑regulation of collagen synthesis, AMPK suppression that diminishes lysosomal biogenesis, or impaired CD206 recycling—the system stalls. Accumulated bioactive fragments then engage integrin α2β1 on adipocytes, triggering NF‑κB‑driven inflammation and insulin resistance. Thus, fibrosis reflects a failure of an ordered clearance pathway, not a passive buildup of garbage.

Novel mechanistic twist We propose that collagen VI, beyond its structural role, acts as a molecular “landing pad” that presents collagen I fragments to CD206 on macrophage surfaces. Collagen VI’s triple‑helix domains bind specific gelatinase‑generated motifs, increasing the local concentration of substrates for CD206. Simultaneously, collagen VI‑derived cryptic peptides (generated by MMP‑9) act as autocrine agonists for the macrophage receptor CXCR4, promoting a survival‑biased M2 phenotype that sustains CD206 expression. In obesity, hypoxia‑induced ROS oxidizes critical methionine residues in collagen VI, reducing its affinity for both fragments and CXCR4 ligands, thereby uncoupling the scaffold from its signaling function.

Testable predictions

1. **Rescue by collagen VI m

Hypothesis

Chronic elevation of mitochondrial DNA heteroplasmy above ~40% disrupts the secretion of mitochondrial‑derived peptides (MDPs) such as humanin and MOTS‑c, leading to aberrant nuclear lamina remodeling and sustained epigenetic drift that cannot be permanently corrected by OSK alone. Reducing mtDNA heteroplasmy below this threshold restores physiological MDP signaling, which in turn stabilizes lamin A processing and permits OSK‑driven demethylation to persist after transgene clearance.

Rationale

• iPSC clones with high mtDNA deletion heteroplasmy show slowed growth, increased epigenetic age, and a senescence‑like transcriptome that persists after differentiation【1】.
• Mitochondrial stress activates retrograde pathways (AMPK, PGC‑1α, HIF‑1α, NF‑κB) that alter NAD⁺/metabolite ratios and drive nuclear hypermethylation【2】.
• Partial reprogramming with OSK reverses nuclear epigenetic age and extends mouse lifespan, but benefits fade when mtDNA heteroplasmy remains high and epigenetic marks revert after treatment stops【3】【4】.
• Recent work demonstrates that MDPs regulate lamin A/C processing and chromatin organization via direct interaction with LAP2α, linking mitochondrial health to nuclear architecture【5】.

We propose that the missing link is MDP‑mediated control of lamin A isoform balance: high heteroplasmy suppresses MDP release, causing accumulation of pre‑lamin A and progerin‑like species that tether heterochromatin to the nuclear periphery, reinforcing methylation patterns that OSK can only transiently overcome.

Predictions

1. In aged mice, liver hetero